Yuluğ, Burak2022-03-082022-03-082009Parlayan, E. vd. (2009). "Neurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effect". Journal of Neuropsychiatry and Clinical Neurosciences, 21(3), 348-350.0895-0172https://doi.org/10.1176/jnp.2009.21.3.348https://neuro.psychiatryonline.org/doi/full/10.1176/jnp.2009.21.3.348http://hdl.handle.net/11452/24909eninfo:eu-repo/semantics/closedAccessNeurosciences & neurologyPsychiatryAgedAspartic acidBrainCognition disordersDementiaFemaleHumansIndansMagnetic resonance spectroscopyMaleMiddle agedNeuroprotective agentsNeuropsychological testsPhenylcarbamatesPiperidinesPsychiatric status rating scalesTreatment outcomeNeurometabolic correlations of donepezil and rivastigmine in dementia patients: A different neuroprotective effectLetter0002700989000232-s2.0-7034963325134835021319776323Clinical neurologyNeurosciencesPsychiatryCreatine; N Acetylaspartic Acid; Cognitive DysfunctionCholine esterase inhibitorDonepezilNeuroprotective agentRivastigmineUnclassified drugAlzheimer diseaseCognitionComputer assisted tomographyDementiaEnzyme inhibitionHumanLetterNeuroprotectionNuclear magnetic resonance imagingNuclear magnetic resonance spectroscopyPriority journal